Get the Stockscreener App
2.16
11.34%
0.22
After Hours:
2.20
0.04
+1.85%
Oncology Institute Inc stock is traded at $2.16, with a volume of 923.86K.
It is up +11.34% in the last 24 hours and up +208.13% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
See More
Previous Close:
$1.94
Open:
$1.94
24h Volume:
923.86K
Relative Volume:
1.08
Market Cap:
$171.13M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-2.7342
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
+27.81%
1M Performance:
+208.13%
6M Performance:
+536.23%
1Y Performance:
+84.62%
1-Day Range:
$1.91
$2.26
1-Week Range:
$1.62
$2.35
52-Week Range:
$0.1253
$2.35
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
2.16 | 171.13M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
335.01 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.65 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
140.03 | 12.07B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
121.81 | 11.79B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
174.80 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 161% Share Price Climb - simplywall.st
Oncology Institute regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Oncology Institute regains Nasdaq compliance with bid price - Investing.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into The Oncology Institute, Inc. - ACCESS Newswire
A Data-Based Look At Oncology Institute Inc (TOI) - stocksregister.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology Institute, Inc. - ACCESS Newswire
Virtu Financial LLC Takes $41,000 Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo Finance
TOI Launches Florida Oncology Network, a Fully Delegated - GlobeNewswire
The Oncology Institute announces launch of the Florida Oncology Network - TipRanks
Healthcare Expansion: TOI Unveils Florida Cancer Network, Secures 80K Patient Contracts - Stock Titan
The oncology institute targets profitability and $460M-$480M revenue in 2025 - MSN
Oncology institute CEO acquires $23,584 in stock By Investing.com - Investing.com Australia
Oncology institute’s chief medical officer buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute Executives Make Bold Moves with Major Stock Purchases - TipRanks
Oncology institute director Karen Johnson acquires $37,734 in shares By Investing.com - Investing.com South Africa
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase By Investing.com - Investing.com Canada
Oncology institute director Brad Hively acquires $9,433 in stock By Investing.com - Investing.com South Africa
Oncology institute director Mark Pacala acquires $94,338 in stock By Investing.com - Investing.com South Africa
Oncology institute’s chief medical officer buys $9,433 in stock - Investing.com India
Oncology institute director Mark Pacala acquires $94,338 in stock - Investing.com India
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase - Investing.com
Oncology Institute Executives Make Significant Stock Purchases - TradingView
Oncology institute director Karen Johnson acquires $37,734 in shares - Investing.com
Oncology institute CFO Robert Ross buys $9,433 in stock - Investing.com India
Oncology institute CFO Robert Ross buys $9,433 in stock By Investing.com - Investing.com South Africa
Oncology institute director Richard Barasch acquires $1.42 million in shares By Investing.com - Investing.com South Africa
Oncology institute director Richard Barasch acquires $1.42 million in shares - Investing.com India
Oncology Institute, Inc. Earnings Call: Growth Amid Challenges - MSN
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2024 Earnings Call Transcript - Insider Monkey
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million - Yahoo Finance
The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada
The Oncology Institute Reports Strong Q4 Revenue Growth - TipRanks
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth - Investing.com Australia
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth By Investing.com - Investing.com South Africa
The Oncology Institute Announces $16.5 million Private Placement - GlobeNewswire
The Oncology Institute Secures $16.5 Million In Private Placement - Nasdaq
Oncology Institute, Inc. Prepares for PIPE Financing - TipRanks
The Oncology Institute, Inc. Announces $16.5 Million Private Placement Agreement - Nasdaq
Oncology Institute Achieves 17% Growth: Mixed Q4 Results Show Path to Profitability - StockTitan
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 - GlobeNewswire
Oncology Institute Lands Major $16.5M Backing as Insiders Double Down - Stock Titan
Wilmot Cancer Institute earns prestigious National Cancer Institute designation - THE WELLSVILLE SUN
Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary - 24-7 Press Release Newswire
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):